KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Change in Receivables (2016 - 2025)

Quest Diagnostics' Change in Receivables history spans 17 years, with the latest figure at -$47.0 million for Q4 2025.

  • For Q4 2025, Change in Receivables rose 31.88% year-over-year to -$47.0 million; the TTM value through Dec 2025 reached $106.0 million, up 49.3%, while the annual FY2025 figure was $106.0 million, 49.3% up from the prior year.
  • Change in Receivables for Q4 2025 was -$47.0 million at Quest Diagnostics, down from $38.0 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $220.0 million in Q3 2021 and bottomed at -$138.0 million in Q1 2021.
  • The 5-year median for Change in Receivables is -$16.0 million (2022), against an average of -$6.8 million.
  • The largest annual shift saw Change in Receivables crashed 179.38% in 2021 before it surged 1500.0% in 2025.
  • A 5-year view of Change in Receivables shows it stood at -$36.0 million in 2021, then crashed by 133.33% to -$84.0 million in 2022, then increased by 15.48% to -$71.0 million in 2023, then rose by 2.82% to -$69.0 million in 2024, then soared by 31.88% to -$47.0 million in 2025.
  • Per Business Quant, the three most recent readings for DGX's Change in Receivables are -$47.0 million (Q4 2025), $38.0 million (Q3 2025), and $14.0 million (Q2 2025).